Waters Gross Margin 2012-2025 | WAT
Current and historical gross margin for Waters (WAT) over the last 10 years. The current gross profit margin for Waters as of September 30, 2025 is %.
| Waters Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $3.11B | $1.83B | 58.95% |
| 2025-06-30 | $3.05B | $1.80B | 59.03% |
| 2025-03-31 | $2.98B | $1.77B | 59.25% |
| 2024-12-31 | $2.96B | $1.76B | 59.41% |
| 2024-09-30 | $2.91B | $1.74B | 59.72% |
| 2024-06-30 | $2.88B | $1.72B | 59.65% |
| 2024-03-31 | $2.91B | $1.74B | 59.68% |
| 2023-12-31 | $2.96B | $1.76B | 59.55% |
| 2023-09-30 | $3.00B | $1.77B | 59.06% |
| 2023-06-30 | $2.99B | $1.75B | 58.48% |
| 2023-03-31 | $2.97B | $1.72B | 57.90% |
| 2022-12-31 | $2.97B | $1.72B | 57.95% |
| 2022-09-30 | $2.95B | $1.70B | 57.56% |
| 2022-06-30 | $2.90B | $1.69B | 58.10% |
| 2022-03-31 | $2.87B | $1.68B | 58.54% |
| 2021-12-31 | $2.79B | $1.63B | 58.44% |
| 2021-09-30 | $2.74B | $1.61B | 58.79% |
| 2021-06-30 | $2.67B | $1.55B | 58.08% |
| 2021-03-31 | $2.51B | $1.46B | 58.09% |
| 2020-12-31 | $2.37B | $1.36B | 57.40% |
| 2020-09-30 | $2.30B | $1.31B | 57.04% |
| 2020-06-30 | $2.28B | $1.31B | 57.68% |
| 2020-03-31 | $2.36B | $1.36B | 57.57% |
| 2019-12-31 | $2.41B | $1.40B | 58.02% |
| 2019-09-30 | $2.41B | $1.41B | 58.50% |
| 2019-06-30 | $2.41B | $1.41B | 58.52% |
| 2019-03-31 | $2.40B | $1.41B | 58.72% |
| 2018-12-31 | $2.42B | $1.43B | 58.97% |
| 2018-09-30 | $2.39B | $1.42B | 59.20% |
| 2018-06-30 | $2.38B | $1.41B | 59.20% |
| 2018-03-31 | $2.34B | $1.39B | 59.14% |
| 2017-12-31 | $2.31B | $1.36B | 59.03% |
| 2017-09-30 | $2.25B | $1.32B | 58.77% |
| 2017-06-30 | $2.21B | $1.30B | 58.82% |
| 2017-03-31 | $2.19B | $1.29B | 58.79% |
| 2016-12-31 | $2.17B | $1.28B | 58.81% |
| 2016-09-30 | $2.13B | $1.25B | 58.65% |
| 2016-06-30 | $2.10B | $1.23B | 58.71% |
| 2016-03-31 | $2.06B | $1.20B | 58.45% |
| 2015-12-31 | $2.04B | $1.20B | 58.74% |
| 2015-09-30 | $2.04B | $1.20B | 58.92% |
| 2015-06-30 | $2.03B | $1.20B | 59.01% |
| 2015-03-31 | $2.02B | $1.19B | 59.09% |
| 2014-12-31 | $1.99B | $1.17B | 58.54% |
| 2014-09-30 | $1.97B | $1.15B | 58.35% |
| 2014-06-30 | $1.94B | $1.13B | 58.14% |
| 2014-03-31 | $1.90B | $1.11B | 58.19% |
| 2013-12-31 | $1.90B | $1.12B | 58.91% |
| 2013-09-30 | $1.86B | $1.10B | 59.03% |
| 2013-06-30 | $1.85B | $1.10B | 59.31% |
| 2013-03-31 | $1.85B | $1.11B | 59.79% |
| 2012-12-31 | $1.84B | $1.11B | 59.96% |
| 2012-09-30 | $1.84B | $1.11B | 60.21% |
| 2012-06-30 | $1.85B | $1.12B | 60.42% |
| 2012-03-31 | $1.84B | $1.12B | 60.52% |
| 2011-12-31 | $1.85B | $1.12B | 60.53% |
| 2011-09-30 | $1.82B | $1.10B | 60.50% |
| 2011-06-30 | $1.76B | $1.06B | 60.31% |
| 2011-03-31 | $1.70B | $1.03B | 60.21% |
| 2010-12-31 | $1.64B | $0.99B | 60.22% |
| 2010-09-30 | $1.59B | $0.96B | 60.10% |
| 2010-06-30 | $1.56B | $0.94B | 60.05% |
| 2010-03-31 | $1.53B | $0.92B | 60.04% |
| 2009-12-31 | $1.50B | $0.91B | 60.37% |
| 2009-09-30 | $1.49B | $0.89B | 59.95% |
| 2009-06-30 | $1.50B | $0.90B | 59.93% |
| 2009-03-31 | $1.54B | $0.90B | 58.85% |
| 2008-12-31 | $1.58B | $0.91B | 58.03% |
| 2008-09-30 | $1.59B | $0.92B | 57.90% |
| 2008-06-30 | $1.56B | $0.89B | 57.27% |
| 2008-03-31 | $1.52B | $0.87B | 57.43% |
| 2007-12-31 | $1.47B | $0.84B | 57.12% |
| 2007-09-30 | $1.42B | $0.81B | 57.02% |
| 2007-06-30 | $1.37B | $0.79B | 57.36% |
| 2007-03-31 | $1.32B | $0.76B | 57.76% |
| 2006-12-31 | $1.28B | $0.75B | 58.20% |
| 2006-09-30 | $1.23B | $0.72B | 58.61% |
| 2006-06-30 | $1.20B | $0.70B | 58.65% |
| 2006-03-31 | $1.18B | $0.69B | 58.81% |
| 2005-12-31 | $1.16B | $0.68B | 58.81% |
| 2005-09-30 | $1.15B | $0.68B | 58.87% |
| 2005-06-30 | $1.14B | $0.67B | 58.93% |
| 2005-03-31 | $1.12B | $0.66B | 59.00% |
| 2004-12-31 | $1.10B | $0.65B | 58.88% |
| 2004-09-30 | $1.06B | $0.62B | 58.58% |
| 2004-06-30 | $1.02B | $0.60B | 58.73% |
| 2004-03-31 | $0.99B | $0.58B | 58.57% |
| 2003-12-31 | $0.96B | $0.56B | 58.46% |
| 2003-09-30 | $0.94B | $0.55B | 58.15% |
| 2003-06-30 | $0.93B | $0.54B | 58.05% |
| 2003-03-31 | $0.91B | $0.53B | 58.02% |
| 2002-12-31 | $0.89B | $0.52B | 58.16% |
| 2002-09-30 | $0.88B | $0.48B | 54.20% |
| 2002-06-30 | $0.87B | $0.48B | 55.47% |
| 2002-03-31 | $0.86B | $0.49B | 56.58% |
| 2001-12-31 | $0.86B | $0.50B | 57.91% |
| 2001-09-30 | $0.84B | $0.54B | 63.92% |
| 2001-06-30 | $0.83B | $0.53B | 63.80% |
| 2001-03-31 | $0.82B | $0.52B | 63.97% |
| 2000-12-31 | $0.80B | $0.51B | 63.90% |
| 2000-09-30 | $0.77B | $0.49B | 63.90% |
| 2000-06-30 | $0.75B | $0.48B | 63.95% |
| 2000-03-31 | $0.72B | $0.46B | 63.81% |
| 1999-12-31 | $0.70B | $0.45B | 63.64% |
| 1999-09-30 | $0.68B | $0.43B | 63.05% |
| 1999-06-30 | $0.66B | $0.42B | 62.59% |
| 1999-03-31 | $0.64B | $0.40B | 62.34% |
| 1998-12-31 | $0.62B | $0.37B | 59.61% |
| 1998-09-30 | $0.59B | $0.33B | 56.42% |
| 1998-06-30 | $0.55B | $0.31B | 56.15% |
| 1998-03-31 | $0.50B | $0.28B | 55.98% |
| 1997-12-31 | $0.47B | $0.28B | 59.35% |
| 1997-09-30 | $0.42B | $0.27B | 63.44% |
| 1997-06-30 | $0.42B | $0.26B | 62.59% |
| 1997-03-31 | $0.41B | $0.25B | 61.67% |
| 1996-12-31 | $0.39B | $0.24B | 61.28% |
| 1996-09-30 | $0.37B | $0.19B | 52.57% |
| 1996-06-30 | $0.35B | $0.19B | 52.84% |
| 1996-03-31 | $0.34B | $0.21B | 62.35% |
| 1995-12-31 | $0.33B | $0.21B | 61.86% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $23.844B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $240.247B | 28.55 |
| Intuitive Surgical (ISRG) | United States | $188.491B | 72.03 |
| IDEXX Laboratories (IDXX) | United States | $55.181B | 54.80 |
| Edwards Lifesciences (EW) | United States | $49.001B | 32.86 |
| IQVIA Holdings (IQV) | United States | $40.710B | 22.70 |
| Alcon (ALC) | Switzerland | $40.074B | 27.01 |
| Mettler-Toledo (MTD) | United States | $29.378B | 34.37 |
| DexCom (DXCM) | United States | $28.830B | 39.74 |
| STERIS (STE) | Ireland | $25.607B | 26.43 |
| Coloplast (CLPBY) | Denmark | $19.494B | 33.27 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.744B | 0.00 |
| Hologic (HOLX) | United States | $16.742B | 17.59 |
| Penumbra (PEN) | United States | $14.041B | 98.77 |
| Globus Medical (GMED) | United States | $12.667B | 26.58 |
| Masimo (MASI) | United States | $7.731B | 24.77 |
| Glaukos (GKOS) | United States | $7.231B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.112B | 19.42 |
| TransMedics (TMDX) | United States | $4.719B | 55.91 |
| Teleflex (TFX) | United States | $4.644B | 7.40 |
| LivaNova (LIVN) | United Kingdom | $3.488B | 18.84 |
| Veracyte (VCYT) | United States | $3.462B | 39.46 |
| Integer Holdings (ITGR) | United States | $2.997B | 14.07 |
| Elekta AB (EKTAY) | Sweden | $2.473B | 23.14 |
| Alphatec Holdings (ATEC) | United States | $2.347B | 0.00 |
| Artivion (AORT) | United States | $2.081B | 95.48 |
| UFP Technologies (UFPT) | United States | $2.057B | 27.15 |
| Nihon Kohden (NHNKY) | Japan | $2.028B | 17.70 |
| PROCEPT BioRobotics (PRCT) | United States | $1.717B | 0.00 |
| AxoGen (AXGN) | United States | $1.476B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.396B | 0.00 |
| IRadimed (IRMD) | United States | $1.322B | 62.96 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.986B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.950B | 5.14 |
| Pacific Biosciences Of California (PACB) | United States | $0.806B | 0.00 |
| SiBone (SIBN) | United States | $0.734B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.727B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.667B | 38.78 |
| Alpha Tau Medical (DRTS) | Israel | $0.608B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.608B | 12.13 |
| NeuroPace (NPCE) | United States | $0.568B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.548B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.477B | 13.18 |
| OrthoPediatrics (KIDS) | United States | $0.464B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.438B | 0.00 |
| RxSight (RXST) | United States | $0.405B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.388B | 64.59 |
| Sight Sciences (SGHT) | United States | $0.339B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Anteris Technologies Global (AVR) | Australia | $0.271B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.270B | 0.00 |
| 908 Devices (MASS) | United States | $0.253B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.203B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.195B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Neuronetics (STIM) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.135B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.133B | 0.00 |
| Solana (HSDT) | United States | $0.133B | 0.00 |
| Hyperfine (HYPR) | United States | $0.121B | 0.00 |
| Accuray (ARAY) | United States | $0.094B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.085B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.74 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |